Remaining Resilient after 2020: Utilizing Cleanrooms on Demand to Accelerate Early-Phase Biopharmaceutical Manufacturing
Time: 3:00 pm
day: Day Two
Details:
- Current industry challenges around the transition from R&D through early phase clinical manufacturing
- Unique challenges with novel therapeutics such as Cell and Gene Therapy and Microbiome based therapies
- Comparison of existing options to overcome such challenges versus Cleanrooms on Demand
